Concepedia

Xia Li

XL

124

Publications

7.5K

Citations

49

H-Index

1994

Active since

Affiliations

Eli Lilly (United States)(Current)

National Institute on Drug Abuse

Huazhong University of Science and Technology

University of California San Diego

Union Hospital

Xia Li is an author at Eli Lilly (United States) specializing in medicine, social sciences, and neuropharmacology.

ORCID

Top concepts

Publications per year

1994–2024

124

Publications

124

Marketing innovations during a global crisis: A study of China firms’ response to COVID-19

Yonggui Wang, Aoran Hong, Xia Li et al. · Journal of Business Research · 2020 · 443 citations · Full text

, , +11

Immunohistochemical localization of ORL-1 in the central nervous system of the rat

Benito Antón, Jeffrey Fein, Trang To et al. · The Journal of Comparative Neurology · 1996 · 288 citations

Human Immunodeficiency Virus Type 1 Enters Brain Microvascular Endothelia by Macropinocytosis Dependent on Lipid Rafts and the Mitogen-Activated Protein Kinase Signaling Pathway

Nancy Q. Liu, A. S. Lossinsky, Waldemar Popik et al. · Journal of Virology · 2002 · 278 citations · Full text

Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages/microglia polarization and affords neuroprotection after spinal cord injury

Hong Fan, Hai‐Bin Tang, Zhe Chen et al. · Journal of Neuroinflammation · 2020 · 258 citations · Full text

Intra- and interstrain differences in models of “behavioral despair”

Fengju Bai, Xia Li, Michael P. Clay et al. · Pharmacology Biochemistry and Behavior · 2001 · 245 citations

, , +4

Rows per page

1–5 of 124